4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine

C69H63BBr2F9N17O9 — CID 165019392

IUPAC4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine
SMILESCC(N)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(-c2ccn3nc(N)nc3c2)c2cn[nH]c2c1)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(Br)c2cn[nH]c2c1)c1ccccc1OC(F)(F)F.CC1(C)OB(c2ccn3nc(N)nc3c2)OC1(C)C.O=C(O)c1cc(Br)c2cn[nH]c2c1
InChIInChI=1S/C23H18F3N7O2.C17H13BrF3N3O2.C12H17BN4O2.C9H10F3NO.C8H5BrN2O2/c1-12(15-4-2-3-5-19(15)35-23(24,25)26)29-21(34)14-8-16(17-11-28-31-18(17)9-14)13-6-7-33-20(10-13)30-22(27)32-33;1-9(11-4-2-3-5-15(11)26-17(19,20)21)23-16(25)10-6-13(18)12-8-22-24-14(12)7-10;1-11(2)12(3,4)19-13(18-11)8-5-6-17-9(7-8)15-10(14)16-17;1-6(13)7-4-2-3-5-8(7)14-9(10,11)12;9-6-1-4(8(12)13)2-7-5(6)3-10-11-7/h2-12H,1H3,(H2,27,32)(H,28,31)(H,29,34);2-9H,1H3,(H,22,24)(H,23,25);5-7H,1-4H3,(H2,14,16);2-6H,13H2,1H3;1-3H,(H,10,11)(H,12,13)
InChIKeyKXVSSDYRQFSPBU-UHFFFAOYSA-N
MW1615.97 g/mol
LogP14.20
Rot. Bonds13

About 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine

4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine (PubChem CID 165019392) has the molecular formula C69H63BBr2F9N17O9 and a molecular weight of 1615.97 g/mol. Its IUPAC name is 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine.

Molecular Properties

Compound Name4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine
PubChem CID165019392
Molecular FormulaC69H63BBr2F9N17O9
Molecular Weight1615.97 g/mol
Exact Mass1613.33
IUPAC Name4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine
SMILESCC(N)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(-c2ccn3nc(N)nc3c2)c2cn[nH]c2c1)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(Br)c2cn[nH]c2c1)c1ccccc1OC(F)(F)F.CC1(C)OB(c2ccn3nc(N)nc3c2)OC1(C)C.O=C(O)c1cc(Br)c2cn[nH]c2c1
InChIInChI=1S/C23H18F3N7O2.C17H13BrF3N3O2.C12H17BN4O2.C9H10F3NO.C8H5BrN2O2/c1-12(15-4-2-3-5-19(15)35-23(24,25)26)29-21(34)14-8-16(17-11-28-31-18(17)9-14)13-6-7-33-20(10-13)30-22(27)32-33;1-9(11-4-2-3-5-15(11)26-17(19,20)21)23-16(25)10-6-13(18)12-8-22-24-14(12)7-10;1-11(2)12(3,4)19-13(18-11)8-5-6-17-9(7-8)15-10(14)16-17;1-6(13)7-4-2-3-5-8(7)14-9(10,11)12;9-6-1-4(8(12)13)2-7-5(6)3-10-11-7/h2-12H,1H3,(H2,27,32)(H,28,31)(H,29,34);2-9H,1H3,(H,22,24)(H,23,25);5-7H,1-4H3,(H2,14,16);2-6H,13H2,1H3;1-3H,(H,10,11)(H,12,13)
InChIKeyKXVSSDYRQFSPBU-UHFFFAOYSA-N
XLogP14.20
TPSA366.13 Ų
H-Bond Donors9
H-Bond Acceptors20
Rotatable Bonds13
Heavy Atoms107
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001615.97
LogP ≤ 514.20
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine?
The IUPAC name of 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine (CID 165019392) is 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine.
What is the SMILES notation for 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine?
The canonical SMILES for 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine is CC(N)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(-c2ccn3nc(N)nc3c2)c2cn[nH]c2c1)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(Br)c2cn[nH]c2c1)c1ccccc1OC(F)(F)F.CC1(C)OB(c2ccn3nc(N)nc3c2)OC1(C)C.O=C(O)c1cc(Br)c2cn[nH]c2c1.
What is the InChIKey of 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine?
The InChIKey is KXVSSDYRQFSPBU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H18F3N7O2.C17H13BrF3N3O2.C12H17BN4O2.C9H10F3NO.C8H5BrN2O2/c1-12(15-4-2-3-5-19(15)35-23(24,25)26)29-21(34)14-8-16(17-11-28-31-18(17)9-14)13-6-7-33-20(10-13)30-22(27)32-33;1-9(11-4-2-3-5-15(11)26-17(19,20)21)23-16(25)10-6-13(18)12-8-22-24-14(12)7-10;1-11(2)12(3,4)19-13(18-11)8-5-6-17-9(7-8)15-10(14)16-17;1-6(13)7-4-2-3-5-8(7)14-9(10,11)12;9-6-1-4(8(12)13)2-7-5(6)3-10-11-7/h2-12H,1H3,(H2,27,32)(H,28,31)(H,29,34);2-9H,1H3,(H,22,24)(H,23,25);5-7H,1-4H3,(H2,14,16);2-6H,13H2,1H3;1-3H,(H,10,11)(H,12,13).
What are the key properties of 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine?
4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine has a molecular weight of 1615.97 g/mol, XLogP of 14.20, 13 rotatable bonds, 9 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;4-bromo-1H-indazole-6-carboxylic acid;4-bromo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]-1H-indazole-6-carboxamide;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine is sourced from PubChem (CID 165019392), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).